Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hallberg

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Molecular Biosciences|April 19, 2021
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based InhibitorsSudarsana Reddy Vanga, Johan Åqvist, Anders Hallberg, et al.
Journal of Medicinal Chemistry|July 25, 2003
Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis modelMalin Graffner-Nordberg, Meredith Fyfe, Ralph Brattsand, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
New potent C2-symmetric malaria plasmepsin I and II inhibitorsKarin Oscarsson, Stefan Oscarson, Lotta Vrang, et al.
Journal of Molecular Graphics & Modelling|December 14, 2002
Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeabilitySusanne Winiwarter, Fredrik Ax, Hans Lennernäs, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 29, 2004
Design, synthesis, and computational affinity prediction of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis cariniiMalin Graffner-Nordberg, Karin Kolmodin, Johan Aqvist, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structural determinants of subtype selectivity and functional activity of angiotensin II receptorsJessica Sallander, Charlotta Wallinder, Anders Hallberg, et al.
Bioorganic & Medicinal Chemistry|January 18, 2005
Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'Anna Ax, Wesley Schaal, Lotta Vrang, et al.
European Journal of Pharmacology|December 6, 2012
Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cellsMarie-Odile Guimond, Charlotta Wallinder, Mathias Alterman, et al.
European Journal of Medicinal Chemistry|December 8, 2014
Aspartic protease inhibitors containing tertiary alcohol transition-state mimicsHitesh V Motwani, Maria De Rosa, Luke R Odell, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitorsKarin Oscarsson, Anton Poliakov, Stefan Oscarson, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Molecular Biosciences|April 19, 2021
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based InhibitorsSudarsana Reddy Vanga, Johan Åqvist, Anders Hallberg, et al.
Journal of Medicinal Chemistry|July 25, 2003
Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis modelMalin Graffner-Nordberg, Meredith Fyfe, Ralph Brattsand, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
New potent C2-symmetric malaria plasmepsin I and II inhibitorsKarin Oscarsson, Stefan Oscarson, Lotta Vrang, et al.
Journal of Molecular Graphics & Modelling|December 14, 2002
Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeabilitySusanne Winiwarter, Fredrik Ax, Hans Lennernäs, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 29, 2004
Design, synthesis, and computational affinity prediction of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis cariniiMalin Graffner-Nordberg, Karin Kolmodin, Johan Aqvist, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structural determinants of subtype selectivity and functional activity of angiotensin II receptorsJessica Sallander, Charlotta Wallinder, Anders Hallberg, et al.
Bioorganic & Medicinal Chemistry|January 18, 2005
Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'Anna Ax, Wesley Schaal, Lotta Vrang, et al.
European Journal of Pharmacology|December 6, 2012
Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cellsMarie-Odile Guimond, Charlotta Wallinder, Mathias Alterman, et al.
European Journal of Medicinal Chemistry|December 8, 2014
Aspartic protease inhibitors containing tertiary alcohol transition-state mimicsHitesh V Motwani, Maria De Rosa, Luke R Odell, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitorsKarin Oscarsson, Anton Poliakov, Stefan Oscarson, et al.
Pageof 11